Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, specifically related to the company's financial disclosures and performance claims [1][2]. Company Overview - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 and entered into transition services agreements with Labcorp [3]. Allegations - The lawsuit alleges that Fortrea overstated the cost savings and margin improvements expected from exiting the transition services agreements, as well as the revenue from pre-spin projects [4]. Stock Performance - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and the full year 2024, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 [6].

文 ｜ 陈佳惠 编辑 ｜ 陈桐 来源｜ 职场Bonus（ID：ZhiChangHonhLi） 封面来源 ｜ 许丹青于"职场Bonus"春季人才沙龙 大部分百万年薪背后，总有红利加持。 虽然百万年薪如今已成为无数公众号在标题中拿来调侃的标签，但须承认并不容易做到。每个百万年薪故事的背 后，都有大量的红利在助推。地区、行业、导师、职业、个人天赋……我们认为这些维度决定了一个人职业发展 的胜算。 年薪多少不代表衡量成功与幸福的唯一标准，我们既不想教大家"厚黑学"，也不想写"幸存者偏差"的故事。这个 系列，将会带你挖掘每位年薪百万的受访者在关键之时所做出的选择，以及他们对未来的创想，愿我们能从中看 见，红利潮水的方向。 "我一天能工作15个小时，但是我并不提倡大家这样，因为我是一直习惯了这样。" 以下文章来源于职场Bonus ，作者陈佳惠 职场Bonus . 职场看红利，事业不焦虑。36氪职场风向报道，像投资人一样寻找未来职业机遇。 真正的巅峰，在下一个十年。 当谈到女性创业时，人们的第一反应往往是，先将她们过往的光辉成就抛之脑后，而对她们关于"工作和家庭的平衡"更感兴趣。 许丹青也不例外。她开始频繁受访之后，没少被 ...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

嘉宾：黄柯鑫 访谈：Penny、Cage 随着语言模型在强化学习和 agentic 领域的进步，agent 正在从通用领域快速渗透到垂直领域，科学和生物医药这类高价值领域尤其受到关注。如 果说 AlphaFold 在 foundation model 层面是生命科学的重要里程碑，AI scientist 就是在 agent 层面，能够给科研带来和 alphafold 同样重要的影响。 今年 5 月，前谷歌 CEO Eric Schmidt 投资的 AI lab FutureHouse 推出了四款 AI scientist agent，一个月后，他们又宣布自己的 AI 系统 Robin 成功发 现了新药。两天前，OpenAI 也发布博客强调 AI 在生物学领域的能力正在不断增强。AI scientist 已经在改写科研和药物开发范式。 随着 multi-agent 技术的发展，AI 可能不再只是"工具箱"，而是能自主完成跨学科复杂研究，从而推动科学发现走向全新模式。 最近，斯坦福大学也发布了一个生物医学通用 agent Biomni，Biomni 搭建了一个适合 agent 的环境，通过整合不同的工具、数据库、 ...

Core Viewpoint - The Company reported a decline in net asset value (NAV) and total return for the six months ending March 31, 2025, reflecting challenging market conditions and investment performance [3][4][13]. Financial Highlights - NAV per share decreased from 40.55p to 34.48p, representing a total return of -8.19% [4][13]. - Market capitalization fell from £150.60 million to £124.25 million [4]. - Share price also declined from 42.20p to 33.80p, with a share price discount to NAV per share of 1.97% [4]. - Dividends paid per share increased from 1.50p to 2.75p during the period [4][6]. Investment Activity - The Company invested £3.6 million in qualifying companies during the period, maintaining 92.29% of its portfolio in qualifying investments [6][30]. - An offer for subscription launched on October 9, 2024, aimed to raise up to £20 million, with £5.4 million raised by issuing 14 million shares [6][31]. Performance of Qualifying Investments - Positive contributors included Aquis Exchange (+95.8%, +£1.71 million) and Cohort (+26.1%, +£1.12 million) due to increased defense spending [15][16]. - Negative contributors included Kidly (-100.00%, -£1.26 million) which went into administration, and Zoo Digital (-74.3%, -£1.14 million) which issued a disappointing trading update [20][21]. Non-Qualifying Investments - The non-qualifying portfolio saw a decline of £1.27 million, with notable losses in WH Smith and Hollywood Bowl due to a weaker economic outlook [27][28]. - The fixed income portfolio returned +£0.35 million, offsetting some losses from direct equities [29]. Market Outlook - The UK economy is expected to see a modest GDP growth of +1.0% in 2025, supported by increased public spending despite inflation concerns [10][39]. - The AIM index has shown resilience post 'Liberation Day', indicating potential growth opportunities despite ongoing market volatility [12][40]. Portfolio Structure - The Company maintained a strong liquidity position with net cash of £11.7 million and a focus on recurring revenue, which represented 82% of total revenue [26][29]. - The portfolio's weighting to qualifying investments increased to 58.4%, while cash weighting decreased to 7.6% [36].

Carrying a Zacks Rank #3 (Hold) at present, the laboratory service provider is concentrating more on areas that represent major growth opportunities and are expected to grow significantly faster than other therapeutic areas. It maintains a solid pipeline of potential acquisitions that fit its financial strategy and will enhance its organic growth. Additionally, the success of the LaunchPad initiative and a solid financial footing are highly encouraging for the company. Based in Burlington, NC, Labcorp offer ...

If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Fortrea securities. The case is pending in the U.S. District Court for the Southern District of New York and i ...

Core Insights - Research Solutions' Scite platform has signed an indexing agreement with the American Society for Microbiology (ASM), enhancing its position in the competitive AI research landscape [1][2] - The partnership adds ASM's extensive portfolio of peer-reviewed journals to Scite's network, which now includes over 30 major publishers and provides access to more than 1.3 billion indexed citations [2][5] - Scite's Smart Citations technology offers deeper insights into citation patterns, allowing researchers to understand how microbiology research is referenced and utilized [3][5] Company Overview - Research Solutions is a vertical SaaS and AI company that simplifies research workflows for academic institutions and life science companies globally, combining AI-powered tools with access to both open access and paywalled research [7] - The company emphasizes ethical sourcing of information through direct partnerships with publishers, distinguishing itself from competitors that scrape content [5] Industry Context - The indexing agreement with ASM reflects the growing importance of citation intelligence in modern research evaluation, providing a richer framework for understanding scholarly impact [4][5] - ASM, established in 1899, is a leading organization in microbiological research, advocating for open science and evidence-based public policies [8]

Albert Anthony is The Analyst, providing markets commentary and rating stocks using his proven 6-step methodology, having grown over +1 thousand followers on the global investor platform Seeking Alpha since 2023, writing for financial media as a senior analyst for his own equities research firm, Albert Anthony & Co, including for platforms like Investing.com. The Croatian-American author writing under pen name Albert Anthony also is launching a new book called The Analyst: 6 Steps To Picking Stocks For Futu ...

[Music] I'm Isis Julian and I'm a senior software engineer at Morning Star and I work on the intelligence engine. Morning Star is a global leader in providing investment research data and analysis and we pride ourselves in empowering investor success by serving transparent, accessible, and reliable investment information. So, with AI gaining increasing popularity nearing the end of 2022 and early 2023, with a scrappy team of just five engineers, we were able to launch our first ever AI research assistant na ...